RPLP0 has been implicated in various diseases, including cancer. Overexpression or mutations in the RPLP0 gene can lead to aberrant ribosomal function, contributing to tumorigenesis. For instance, elevated levels of RPLP0 have been observed in breast cancer tissues, making it a potential biomarker for cancer diagnosis and prognosis.
